TAmiRNA
TAmiRNA is a biotechnology company specializing in the discovery, validation, and development of RNA biomarkers and diagnostic solutions for precision medicine.
About
TAmiRNA is dedicated to advancing precision medicine by supporting researchers and clinicians in RNA biomarker discovery, validation, and development. The company specializes in the use of cell-free RNAs, including microRNAs, mRNAs, and long non-coding RNAs, for biomarker identification and diagnostics. Integrating AI-driven analysis with advanced transcriptomic platforms, TAmiRNA develops actionable diagnostic solutions to improve disease detection, patient stratification, and outcomes, particularly in age-associated and complex diseases, such as liver disease, cardiovascular disease, oncology, and bone and joint disorders. TAmiRNA also provides research and contract services in biopsy sample analysis, RNA sequencing, and custom biomarker assay development.
Products & Services
- hepatomiR kit (CE-IVD)
- senomiR kit
- toxomiR kit
- osteomiR kit
- thrombomiR kit
- miND spike-ins (NGS controls for small RNAseq)
- custom miRNA and mRNA signature analysis workflows
- targeted RNA analysis (RT-qPCR)
- untargeted RNA analysis (NGS-based transcriptomics)
- extracellular vesicle (EV) purification and characterization
- whole-transcriptome sequencing for mRNA, lncRNA, and circRNA
- bioinformatics pipelines for isomiR and tRNA analysis
- RNA analysis services for biofluids, cells, tissues, and exosomes
Use Cases & Case Studies
- Use of miND spike-ins for absolute quantification in small RNA sequencing
- Application of hepatomiR kit for assessment of liver function and risk of post-hepatectomy liver failure
- Extracellular vesicle characterization for biomarker discovery
- MicroRNA panels for osteoporosis and bone fracture risk assessment
- Monitoring antiplatelet therapy response using thrombomiRs
- Diagnosis and monitoring of metabolic-associated liver disease (MAFLD) and drug-induced liver injury (DILI)
- Research on miRNAs as biomarkers for periprosthetic joint infection diagnosis
- miRNA biomarker services for Type 2 diabetes-related bone fragility
Partnerships & Collaborations
- Partnership with Medical University of Vienna for hepatomiR test development
- Collaboration with Evercyte and Phoenestra in the EVscale™ platform
- Collaboration with BioEcho Life Sciences
- Collaboration with Summit Pharmaceutical International (Japan)
- Collaboration with Techtum Lab for Nordic distribution
- Collaboration with Biogenity
- Collaboration with 7Bioscience for distribution
- Collaboration with Lepton Pharmaceuticals LTD for immune therapy discovery
- Collaboration with Ludwig Boltzmann Institute for Experimental and Clinical Traumatology
- Collaboration with Vivomicx BV and University Medical Center Groningen
Awards & Recognition
- ISO 13485:2016 certification for Medical Device and Quality Management System
- Dr. Michael Nodine’s spike-in technology nominated for Houska Prize (Austria's biggest private prize for applied research)
Contact Information
Certifications & Compliance
- ISO 13485:2016
- CE-IVD certified diagnostic tests